Morning Movers 07/16: (PRX) (ALNY) (CONM) Higher; (ANR) (GDI) Lower
Tweet Send to a Friend
Get Alerts PRX Hot Sheet
Trade PRX Now!
Par Pharmaceutical Companies, Inc. (NYSE: PRX) 38.3% HIGHER; announced today that it has entered into a definitive merger agreement to be acquired by an affiliate of TPG in a transaction valued at $50/share in cash.
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) 22.6% HIGHER; announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis. Click here to see the full report.
Conmed Healthcare Management, Inc. (Amex: CONM) 13.3% HIGHER; and Correct Care Solutions, LLC (CCS) today announced that they have entered into a definitive merger agreement providing for CCS to acquire Conmed, for $3.95 per share in cash.
Alpha Natural Resources (NYSE: ANR) 10.5% LOWER; BMO Capital downgraded the stock from Outperform to Underperform with a price target of $5.00 (from $18.00).
Gardner Denver, Inc. (NYSE: GDI) 10.4% LOWER; today announced that Barry L. Pennypacker has resigned as president, chief executive officer and director. Michael M. Larsen, vice president and chief financial officer, has been named interim CEO, effective immediately.
Zogenix, Inc. (Nasdaq: ZGNX) 9.5% HIGHER; announced today that the U.S. FDA has accepted for review the NDA for Zohydro ER™ (hydrocodone bitartrate extended-release capsules), Zogenix's lead investigational product candidate for the treatment of moderate to severe chronic pain.
AuthenTec, Inc. (Nasdaq: AUTH) 9% HIGHER; is jumping higher after announcing that Samsung has chosen its QuickSec VPN security for use in new Android smartphone and tablet models.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) 22.6% HIGHER; announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin gene for the treatment of TTR-mediated amyloidosis. Click here to see the full report.
Conmed Healthcare Management, Inc. (Amex: CONM) 13.3% HIGHER; and Correct Care Solutions, LLC (CCS) today announced that they have entered into a definitive merger agreement providing for CCS to acquire Conmed, for $3.95 per share in cash.
Alpha Natural Resources (NYSE: ANR) 10.5% LOWER; BMO Capital downgraded the stock from Outperform to Underperform with a price target of $5.00 (from $18.00).
Gardner Denver, Inc. (NYSE: GDI) 10.4% LOWER; today announced that Barry L. Pennypacker has resigned as president, chief executive officer and director. Michael M. Larsen, vice president and chief financial officer, has been named interim CEO, effective immediately.
Zogenix, Inc. (Nasdaq: ZGNX) 9.5% HIGHER; announced today that the U.S. FDA has accepted for review the NDA for Zohydro ER™ (hydrocodone bitartrate extended-release capsules), Zogenix's lead investigational product candidate for the treatment of moderate to severe chronic pain.
AuthenTec, Inc. (Nasdaq: AUTH) 9% HIGHER; is jumping higher after announcing that Samsung has chosen its QuickSec VPN security for use in new Android smartphone and tablet models.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- 50-Day SMA Crossers 05/20: (ELN) (ACI) (AAPL) Above; (MRK) (TLAB) (CLSN) Below
- Streetinsider.com's Hot Lunchtime Reads 05/20: (AAPL) (MKTO) (ELN) (CAT)
- Notable Analyst Rating Changes 05/20: (DANG) (P) (ACN) Upgraded; (LEAP) (LOW) (RHT) Downgraded
Create E-mail Alert Related Categories
Special ReportsRelated Entities
BMO Capital, Morning Movers
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
